Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs
- 1 May 2001
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 90 (2-3) , 231-259
- https://doi.org/10.1016/s0163-7258(01)00139-5
Abstract
No abstract availableKeywords
This publication has 238 references indexed in Scilit:
- Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosetsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- The anticataleptic effect of 7-OH-DPAT: are dopamine D 3 receptors involved?Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- Clozapine, haloperidol, and the D 4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin releaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexoleJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviourJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine releaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Cortical regulation of subcortical dopamine systems and its possible relevance to schizophreniaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonistsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Dopamine D2 receptor density remains constant in treated Parkinson's diseaseAnnals of Neurology, 1986
- The effect of chronic L-DOPA administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brainLife Sciences, 1982